1. Home
  2. NBIX vs HL Comparison

NBIX vs HL Comparison

Compare NBIX & HL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$163.88

Market Cap

13.2B

Sector

Health Care

ML Signal

HOLD

Logo Hecla Mining Company

HL

Hecla Mining Company

HOLD

Current Price

$14.78

Market Cap

13.8B

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBIX
HL
Founded
1992
1891
Country
United States
United States
Employees
N/A
1865
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Precious Metals
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
13.2B
13.8B
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
NBIX
HL
Price
$163.88
$14.78
Analyst Decision
Strong Buy
Buy
Analyst Count
22
8
Target Price
$180.91
$21.13
AVG Volume (30 Days)
1.1M
14.2M
Earning Date
05-05-2026
05-05-2026
Dividend Yield
N/A
0.09%
EPS Growth
41.95
N/A
EPS
1.91
N/A
Revenue
$161,626,000.00
N/A
Revenue This Year
$24.73
$4.92
Revenue Next Year
$13.14
N/A
P/E Ratio
$87.58
$44.94
Revenue Growth
977.51
N/A
52 Week Low
$122.14
$5.60
52 Week High
$169.57
$34.17

Technical Indicators

Market Signals
Indicator
NBIX
HL
Relative Strength Index (RSI) 65.15 32.82
Support Level $134.92 $12.21
Resistance Level N/A $15.77
Average True Range (ATR) 4.51 0.83
MACD 0.13 -0.18
Stochastic Oscillator 67.18 0.65

Price Performance

Historical Comparison
NBIX
HL

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

About HL Hecla Mining Company

Hecla Mining Co produces and explores silver, gold, zinc, and other metals. The operating business segments are Greens Creek, Lucky Friday, Keno Hill, and Casa Berardi. It generates maximum revenue from the Greens Creek segment. Geographically, It operates in Canada, the United States, and Mexico, and it derives a majority of its revenue from the United States.

Share on Social Networks: